Executive Summary

Oct 2019
PROSPECTS
Increased tendency to self-medicate contributes to analgesics’ performance

Weak purchasing power following the devaluation of the local currency in 2016 led to Azerbaijani consumers becoming more rational in their purchasing decisions towards the end of the review period. Consequently, categories including products considered particularly essential saw better growth rates in 2019.

Consumers focus on essentials and their children as spending power weakens

Adult combination analgesics and paediatric analgesics saw the most dynamic performances in 2019. This was underpinned by the essential nature of these products, and the parental desire to take the greatest possible care of their children.

Drugstores/parapharmacies remains the dominant retail channel for analgesics

As with other OTC consumer health product types, analgesics can only be distributed through healthcare specialist retailers approved and accredited by the relevant state regulatory bodies. As a result, drugstores/parapharmacies continued to represent the leading distribution channel for analgesics in 2019.

COMPETITIVE LANDSCAPE
Price a key factor in choice, multinationals’ products perceived as more effective

With increased consumer awareness and continuous advertising, the shares held by multinationals continued to grow in 2019. Multinationals’ products are widely perceived as being more effective and of higher quality, and thus see continued demand.

Paediatric Panadol benefits from brand strength of parental concerns

Highly advertised paediatric Panadol saw notable growth in 2019. In their desire to provide the best for their infants and children, consumers seek quality products in paediatric categories.

New introductions appeal only in short term

Due to the strong consumer loyalty towards established brands, such as Spazmalgon, Tempalgin and Paracetamol, new brands invest in marketing and promotion through pharma channels, including drugstores/parapharmacies and chemists/pharmacists, as well as medical institutions. One of the most promoted new launches in analgesics towards the end of the review period was Spazmblok by Adipharm.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Azerbaijan

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Azerbaijan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Azerbaijan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Azerbaijan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Azerbaijan?
  • What are the major brands in Azerbaijan?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Azerbaijan - Category analysis

HEADLINES

PROSPECTS

Increased tendency to self-medicate contributes to analgesics’ performance
Consumers focus on essentials and their children as spending power weakens
Drugstores/parapharmacies remains the dominant retail channel for analgesics

COMPETITIVE LANDSCAPE

Price a key factor in choice, multinationals’ products perceived as more effective
Paediatric Panadol benefits from brand strength of parental concerns
New introductions appeal only in short term

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Azerbaijan - Industry Overview

EXECUTIVE SUMMARY

Impact of delicate economic balance and constrained consumer spending power evident across the market
Azerbaijani consumers value quality, herbal/traditional products perceived as less potentially harmful
Consumers like international products’ quality, but local products’ prices
Drugstores/parapharmacies remain dominant due to strict controls
Preventative measure and general health trend set to influence market performance, underpinned by economic and demographic factors

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources